MIA
BIO icon

Milestone Investment Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History

Milestone Investment Advisors’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-6
Closed -$2.15K – 162
2023
Q3 		$2.15K Buy
+6
New +$2.31K ﹤0.01% 366
2023
Q2 		– Sell
-5
Closed -$2.4K – 157
2023
Q1 		$2.4K Buy
+5
New +$2.34K ﹤0.01% 364

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Milestone Investment Advisors's BIO Position: Q4 2023 in Review

Milestone Investment Advisors sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2023, closing a stake of 6 shares — an estimated $2.15K sold.

Milestone Investment Advisors first reported a position in BIO in Q1 2023 and held it in 2 quarters. The position peaked at $2.4K in Q1 2023. 483 funds tracked by Wall St. Rank hold BIO as of Q4 2023.

  • Milestone Investment Advisors reported no remaining Bio-Rad Laboratories Class A position as of Q4 2023 after selling out during the quarter.
  • Milestone Investment Advisors sold 6 Bio-Rad Laboratories Class A shares in Q4 2023, an estimated $2.15K.
  • Milestone Investment Advisors first reported a position in Bio-Rad Laboratories Class A in Q1 2023 and held it in 2 quarters.
  • Milestone Investment Advisors's Bio-Rad Laboratories Class A position peaked at $2.4K in Q1 2023.
  • 483 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2023.

Based on Milestone Investment Advisors's 13F filing for Q4 2023, filed 9 Feb 2024.